Monday, 2 November 2026
Independent coverage of global markets, trade and finance
Finance & markets
Policy desk, National Trade News (2026-11-02): The average one-year price target for Theriva Biologics (NYSEAM:TOVX) (DB:SFY0) has been revised to $4.08 / share. This is an increase of 60.00% from the… Primary source: original at Nasdaq (nasdaq.com).
Theriva Biologics Consensus Price Target Raised 60% to $4.08
The average one-year price target for Theriva Biologics (NYSEAM:TOVX) (DB:SFY0) has been revised to $4.08 / share. This is an increase of 60.00% from the prior estimate of $2.55 dated October 20, 2026. These figures represent aggregate analyst targets compiled by Fintel and do no